Differences in activity of minoxidil and cyclosporin A on hair growth in nude and normal mice. Comparisons of in vivo and in vitro studies. 1990

A E Buhl, and D J Waldon, and B F Miller, and M N Brunden
Hairgrowth Research and Biostatistics, Upjohn Company, Kalamazoo, Michigan.

Hair growth effects of minoxidil and cyclosporin A were assessed in a series of experiments using nude mice. Systematic monitoring of coat hair showed that untreated nude mice grow extremely sparse and transient hair in cycles. This monitoring was done by photographing each animal through at least one full growth cycle and rating peak growth on a 1 to 4 scale. Topical administration of minoxidil or minoxidil sulfate did not influence this cyclic hair growth. Orally administered minoxidil also had no effect but oral cyclosporin A increased peak hair growth. None of the treatments altered the length of the hair cycle. Direct drug effects on follicles were tested in vitro using organ cultured vibrissae from both nude and normal mice. Minoxidil stimulated hair growth in follicles from normal but not nude mice. In contrast, cyclosporin A stimulated growth only in vibrissae follicles from nude but not normal animals. These studies show that minoxidil and cyclosporin A influence hair growth differentially. Cyclosporin A directly affects nude hair follicles by apparently compensating for a genetic defect inherent in nude follicles. Minoxidil does not have a similar effect. Apparently, the biochemical pathway activated by minoxidil is not a critical defect of hair growth in nude mice. We conclude that nude mice are not useful for studying minoxidil effects but they may be useful in studying pleiotropic effects of the nude gene on hair growth.

UI MeSH Term Description Entries
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D008914 Minoxidil A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371) Loniten,Regaine,Rogaine,U 10858
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D006197 Hair A filament-like structure consisting of a shaft which projects to the surface of the SKIN from a root which is softer than the shaft and lodges in the cavity of a HAIR FOLLICLE. It is found on most surfaces of the body. Fetal Hair,Hair, Fetal,Lanugo,Fetal Hairs,Hairs,Hairs, Fetal
D000279 Administration, Cutaneous The application of suitable drug dosage forms to the skin for either local or systemic effects. Cutaneous Drug Administration,Dermal Drug Administration,Drug Administration, Dermal,Percutaneous Administration,Skin Drug Administration,Transcutaneous Administration,Transdermal Administration,Administration, Dermal,Administration, Transcutaneous,Administration, Transdermal,Cutaneous Administration,Cutaneous Administration, Drug,Dermal Administration,Drug Administration, Cutaneous,Skin Administration, Drug,Administration, Cutaneous Drug,Administration, Dermal Drug,Administration, Percutaneous,Administrations, Cutaneous,Administrations, Cutaneous Drug,Administrations, Dermal,Administrations, Dermal Drug,Administrations, Percutaneous,Administrations, Transcutaneous,Administrations, Transdermal,Cutaneous Administrations,Cutaneous Administrations, Drug,Cutaneous Drug Administrations,Dermal Administrations,Dermal Drug Administrations,Drug Administrations, Cutaneous,Drug Administrations, Dermal,Drug Skin Administrations,Percutaneous Administrations,Skin Administrations, Drug,Skin Drug Administrations,Transcutaneous Administrations,Transdermal Administrations
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

A E Buhl, and D J Waldon, and B F Miller, and M N Brunden
December 1991, The Journal of dermatology,
A E Buhl, and D J Waldon, and B F Miller, and M N Brunden
June 1987, Laboratory investigation; a journal of technical methods and pathology,
A E Buhl, and D J Waldon, and B F Miller, and M N Brunden
July 1994, Journal of dermatological science,
A E Buhl, and D J Waldon, and B F Miller, and M N Brunden
January 1991, Acta dermato-venereologica,
A E Buhl, and D J Waldon, and B F Miller, and M N Brunden
January 2001, Cells, tissues, organs,
A E Buhl, and D J Waldon, and B F Miller, and M N Brunden
January 2014, ISRN pharmacology,
A E Buhl, and D J Waldon, and B F Miller, and M N Brunden
March 1993, The Journal of investigative dermatology,
A E Buhl, and D J Waldon, and B F Miller, and M N Brunden
August 2015, Pharmaceutical biology,
A E Buhl, and D J Waldon, and B F Miller, and M N Brunden
January 2007, Biological & pharmaceutical bulletin,
A E Buhl, and D J Waldon, and B F Miller, and M N Brunden
October 1996, Dermatologic clinics,
Copied contents to your clipboard!